article thumbnail

STAT+: The CRISPR companies are not OK

STAT

No less an authority than a Nobel Prize committee announced, in 2020, that CRISPR “may make the dream of curing inherited diseases come true.”   The gene editing tool, wrested out of bacteria 13 years ago by a fractious group of biochemists, was supposed to change medicine.

363
363
article thumbnail

STAT+: Pfizer to pay $60 million to settle claims that Biohaven paid kickbacks to doctors

STAT

The authorities alleged that, from March 2020 through September 2022, Biohaven improperly paid doctors speaking fees and for meals at “high end” restaurants in order to persuade them to prescribe Nurtec ODT, the centerpiece of the $11.6 Department of Justice. billion acquisition.

335
335
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Wyden claims Pfizer used a ‘colossal’ scheme to avoid paying billions in U.S. taxes

STAT

for 2018 and 2020. In what one U.S. lawmaker described as possibly the “largest tax-dodging scheme” by a pharmaceutical company in history, Pfizer sold $20 billion in medicines to U.S. customers, but treating the profits as foreign income for tax purposes.

article thumbnail

To tackle race in clinical guidelines, researchers seek alternatives to federal dollars

STAT

After clinical algorithms that use race as a variable came under scrutiny in 2020, several commonly used tools have been revised to align with medicine’s understanding that race is not a biological construct, but a social one. 

256
256
article thumbnail

RFK Jr. calls rising autism rate an ‘epidemic.’ Researchers call it a ‘good sign’

STAT

of kids surveyed in 2020 for the previous report. The Centers for Disease Control and Prevention report says that 3.2% of kids surveyed in 2022 have autism spectrum disorder, a slight uptick from the 2.8% The report also confirmed a recent trend that autism prevalence is higher in non-white kids than in white kids. Read the rest…

359
359
article thumbnail

STAT+: Sutter Health settles sweeping antitrust case, narrowly avoiding trial

STAT

based Sutter want to be repaid for the money they spent on health insurance from 2011 through 2020.   Terms of the settlement were not immediately released on Monday, but it’s likely sizable given the scope of the case. The individuals and businesses suing Sacramento, Calif.-based Continue to STAT+ to read the full story…

Hospitals 305
article thumbnail

STAT+: Why Orexo is abandoning a digital therapeutic for depression

STAT

The companies have worked together on Deprexis in the United States since 2020 and have deals for two other apps, including Modia, an app that provides psychosocial support to people being treated for opioid addiction. Orexo announced this week that it will no longer license the product, called Deprexis, from German manufacturer GAIA.